» Articles » PMID: 25200523

Study of the Medial Group Retropharyngeal Node Metastasis from Nasopharyngeal Carcinoma Based on 3100 Newly Diagnosed Cases

Overview
Journal Oral Oncol
Publisher Elsevier
Specialty Dentistry
Date 2014 Sep 10
PMID 25200523
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Patterns of metastases to the medial retropharyngeal lymph nodes (RPLN) from nasopharyngeal carcinoma (NPC) have gain little attention. Since the incidence of dysphagia was closely related to whether the medial RPLN was irradiated, we carried out a prospective study to explore the patterns of the medial RPLN involvement.

Methods And Materials: Previously untreated NPC patients were required to receive MRI scan. MRI scanning sequences included pre-contrast T1WI, T2WI, and post-contrast T1WI with fat suppression. All images were evaluated by the multi-disciplinary treatment group of NPC.

Results: 3100 cases of NPC entered this study. 2679 (86.4%) cases had involved lymph nodes. The detailed distribution were: 2341 (87.4%) in level IIb, 1798 (67.1%) in level IIa, 1184 (44.2%) in level III, 350 (14.1%) in level IV, 995 (37.1%) in level V, 115(4.3%) in level Ib, 2012 (75.1%) in the retropharyngeal area. But only 6 (0.2%) were located at the medial group, accompanied with the lateral RPLN and other node metastasis. Only one medial RPLN can be identified in a patient, whereas the number of the lateral RPLNs per affected side varied between one and four. The average size of the medial and lateral RPLNs was 8±4 mm (range, 4-17 mm) and 16±9 mm (range, 5-53 mm), respectively.

Conclusions: ① Involvement of the retropharyngeal nodes were mainly located at the lateral group, the medial RPLN was rarely seen. ② Metastasis to the medial RPLN was always accompanied with other node metastasis. ③ Only one medial RPLN can be identified in a patient, whereas the enlarged lateral RPLNs per affected side could be multiple. ④ The average size of the medial RPLN was smaller than the lateral RPLNs.

Citing Articles

Enhancing efficacy and reducing toxicity: Therapeutic optimization in locoregionally advanced nasopharyngeal carcinoma.

Jiang W, Lv J, Tang L, Sun Y, Chen Y, Ma J Cell Rep Med. 2024; 5(6):101594.

PMID: 38843843 PMC: 11228659. DOI: 10.1016/j.xcrm.2024.101594.


Embracing Personalized Strategies in Radiotherapy for Nasopharyngeal Carcinoma: Beyond the Conventional Bounds of Fields and Borders.

Yip P, You R, Chen M, Chua M Cancers (Basel). 2024; 16(2).

PMID: 38254872 PMC: 10814653. DOI: 10.3390/cancers16020383.


Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.

Lin F, Qiu Z, Xie D, Zhou X, Wang L, Wu Z Cancer Med. 2023; 12(21):20511-20520.

PMID: 37881136 PMC: 10660103. DOI: 10.1002/cam4.6614.


Diagnostic Value of Dynamic F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography (F-FDG PET-CT) in Cervical Lymph Node Metastasis of Nasopharyngeal Cancer.

Li G, Yang S, Wang S, Jiang R, Xu X Diagnostics (Basel). 2023; 13(15).

PMID: 37568893 PMC: 10417831. DOI: 10.3390/diagnostics13152530.


Knowing nodal Rouviére: the power of human intelligence in toxicity reduction.

Chan A Cancer Commun (Lond). 2023; 43(5):613-614.

PMID: 37069789 PMC: 10174086. DOI: 10.1002/cac2.12419.